-
1صورة
المؤلفون: Jiaqin Xu, Chen Huang, Zhenyu Wu, Huilin Xu, Jiong Li, Yuntao Chen, Ce Wang, Jingjing Zhu, Guoyou Qin, Xueying Zheng, Yongfu Yu
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, ovarian cancer, second primary malignancies, competing risk model, nomogram, SEER database
الإتاحة: https://doi.org/10.3389/fonc.2022.875489.s003Test
https://figshare.com/articles/figure/Image_3_Risk_Prediction_of_Second_Primary_Malignancies_in_Primary_Early-Stage_Ovarian_Cancer_Survivors_A_SEER-Based_National_Population-Based_Cohort_Study_tif/19794943Test -
2صورة
المؤلفون: Jiaqin Xu, Chen Huang, Zhenyu Wu, Huilin Xu, Jiong Li, Yuntao Chen, Ce Wang, Jingjing Zhu, Guoyou Qin, Xueying Zheng, Yongfu Yu
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, ovarian cancer, second primary malignancies, competing risk model, nomogram, SEER database
الإتاحة: https://doi.org/10.3389/fonc.2022.875489.s001Test
https://figshare.com/articles/figure/Image_1_Risk_Prediction_of_Second_Primary_Malignancies_in_Primary_Early-Stage_Ovarian_Cancer_Survivors_A_SEER-Based_National_Population-Based_Cohort_Study_tif/19794937Test -
3صورة
المؤلفون: Jiaqin Xu, Chen Huang, Zhenyu Wu, Huilin Xu, Jiong Li, Yuntao Chen, Ce Wang, Jingjing Zhu, Guoyou Qin, Xueying Zheng, Yongfu Yu
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, ovarian cancer, second primary malignancies, competing risk model, nomogram, SEER database
الإتاحة: https://doi.org/10.3389/fonc.2022.875489.s002Test
https://figshare.com/articles/figure/Image_2_Risk_Prediction_of_Second_Primary_Malignancies_in_Primary_Early-Stage_Ovarian_Cancer_Survivors_A_SEER-Based_National_Population-Based_Cohort_Study_tif/19794940Test -
4
المؤلفون: Jiaqin Xu, Chen Huang, Zhenyu Wu, Huilin Xu, Jiong Li, Yuntao Chen, Ce Wang, Jingjing Zhu, Guoyou Qin, Xueying Zheng, Yongfu Yu
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, ovarian cancer, second primary malignancies, competing risk model, nomogram, SEER database
الإتاحة: https://doi.org/10.3389/fonc.2022.875489.s006Test
https://figshare.com/articles/dataset/Table_2_Risk_Prediction_of_Second_Primary_Malignancies_in_Primary_Early-Stage_Ovarian_Cancer_Survivors_A_SEER-Based_National_Population-Based_Cohort_Study_docx/19794952Test -
5صورة
المؤلفون: Jiaqin Xu, Chen Huang, Zhenyu Wu, Huilin Xu, Jiong Li, Yuntao Chen, Ce Wang, Jingjing Zhu, Guoyou Qin, Xueying Zheng, Yongfu Yu
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, ovarian cancer, second primary malignancies, competing risk model, nomogram, SEER database
الإتاحة: https://doi.org/10.3389/fonc.2022.875489.s004Test
https://figshare.com/articles/figure/Image_4_Risk_Prediction_of_Second_Primary_Malignancies_in_Primary_Early-Stage_Ovarian_Cancer_Survivors_A_SEER-Based_National_Population-Based_Cohort_Study_tif/19794946Test -
6
المؤلفون: Jiaqin Xu, Chen Huang, Zhenyu Wu, Huilin Xu, Jiong Li, Yuntao Chen, Ce Wang, Jingjing Zhu, Guoyou Qin, Xueying Zheng, Yongfu Yu
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, ovarian cancer, second primary malignancies, competing risk model, nomogram, SEER database
الإتاحة: https://doi.org/10.3389/fonc.2022.875489.s007Test
https://figshare.com/articles/dataset/Table_3_Risk_Prediction_of_Second_Primary_Malignancies_in_Primary_Early-Stage_Ovarian_Cancer_Survivors_A_SEER-Based_National_Population-Based_Cohort_Study_docx/19794955Test -
7
المؤلفون: Jiaqin Xu, Chen Huang, Zhenyu Wu, Huilin Xu, Jiong Li, Yuntao Chen, Ce Wang, Jingjing Zhu, Guoyou Qin, Xueying Zheng, Yongfu Yu
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, ovarian cancer, second primary malignancies, competing risk model, nomogram, SEER database
الإتاحة: https://doi.org/10.3389/fonc.2022.875489.s005Test
https://figshare.com/articles/dataset/Table_1_Risk_Prediction_of_Second_Primary_Malignancies_in_Primary_Early-Stage_Ovarian_Cancer_Survivors_A_SEER-Based_National_Population-Based_Cohort_Study_docx/19794949Test -
8صورة
المؤلفون: Yang Cheng (125394), Kezuo Hou (5050340), Yizhe Wang (2287393), Yang Chen (9737), Xueying Zheng (3609065), Jianfei Qi (129032), Bowen Yang (522998), Shiying Tang (5137418), Xu Han (141301), Dongyao Shi (11018229), Ximing Wang (519685), Yunpeng Liu (379288), Xuejun Hu (2003440), Xiaofang Che (5050337)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, lung adenocarcinoma, prognosis, signature, drug repositioning, gliclazide
-
9صورة
المؤلفون: Yang Cheng, Kezuo Hou, Yizhe Wang, Yang Chen, Xueying Zheng, Jianfei Qi, Bowen Yang, Shiying Tang, Xu Han, Dongyao Shi, Ximing Wang, Yunpeng Liu, Xuejun Hu, Xiaofang Che
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, lung adenocarcinoma, prognosis, signature, drug repositioning, gliclazide
الإتاحة: https://doi.org/10.3389/fonc.2021.665276.s001Test
https://figshare.com/articles/figure/Image_1_Identification_of_Prognostic_Signature_and_Gliclazide_as_Candidate_Drugs_in_Lung_Adenocarcinoma_tif/14835195Test -
10
المؤلفون: Yang Cheng, Kezuo Hou, Yizhe Wang, Yang Chen, Xueying Zheng, Jianfei Qi, Bowen Yang, Shiying Tang, Xu Han, Dongyao Shi, Ximing Wang, Yunpeng Liu, Xuejun Hu, Xiaofang Che
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, lung adenocarcinoma, prognosis, signature, drug repositioning, gliclazide
الإتاحة: https://doi.org/10.3389/fonc.2021.665276.s002Test
https://figshare.com/articles/dataset/Table_1_Identification_of_Prognostic_Signature_and_Gliclazide_as_Candidate_Drugs_in_Lung_Adenocarcinoma_docx/14835201Test